Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexium for persistent GORD symptoms
NCT00734097Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by AstraZeneca. Started Nov 2007; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00734097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00734097.